| Date | Form | Description | Docs | XBRL | Pages |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
19 |
| 01/28/22 | DEF 14A | Definitive proxy statements |
|
17 | |
| 01/13/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/12/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones
Read More...Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Read More...Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...